<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink">
    <mets:dmdSec ID="DMD2941202">
        <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
            <mets:xmlData>
                <mods xmlns="http://www.loc.gov/mods/v3" version="3.7" xmlns:vl="http://visuallibrary.net/vl">
                    <titleInfo>
                        <title>Impact of CRISPR interference on strain development in biotechnology</title>
                    </titleInfo>
                    <name type="personal">
                        <namePart type="given">Kerstin</namePart>
                        <namePart type="family">Schultenkämper</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Luciana</namePart>
                        <namePart type="family">Fernandes de Brito</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <name type="personal">
                        <namePart type="given">Volker F.</namePart>
                        <namePart type="family">Wendisch</namePart>
                        <nameIdentifier type="orcid" typeURI="http://orcid.org">0000-0003-3473-0012</nameIdentifier>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <typeOfResource>text</typeOfResource>
                    <genre authority="dini">article</genre>
                    <originInfo>
                        <dateIssued encoding="w3cdtf">2020</dateIssued>
                    </originInfo>
                    <language>
                        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
                    </language>
                    <abstract lang="eng">Genetic perturbation systems are of great interest to redirect metabolic fluxes for value‐added production, as well as genetic screening for the development of new drugs, or to identify new targets for biotechnological applications. Here, we review CRISPR interference (CRISPRi), a method for gene expression using a catalytically inactive version of the CRISPR‐associated protein 9 (dCas9) of the widely applied CRISPR‐Cas9 genome editing system. In combination with the appropriate sgRNA, dCas9 binds to specific DNA sequences without causing double‐stranded DNA breakage but interfering with transcription initiation or elongation. Besides manifold uses to interrogate the physiology of a bacterial cell, CRISPRi is used in applications for metabolic engineering and strain development in industrial biotechnology. Albeit in its infancy, CRISPRi has already delivered the first success stories; however, we also analyze limitations of the CRISPRi system and give future perspectives.</abstract>
                    <subject>
                    </subject>
                    <classification authority="ddc">570</classification>
                    <relatedItem type="host">
                        <titleInfo>
                            <title>Biotechnology and Applied Biochemistry</title>
                        </titleInfo>
                        <part>
                            <detail type="volume">
                                <number>67</number>
                            </detail>
                            <detail type="issue">
                                <number>1</number>
                            </detail>
                            <extent unit="page">
                                <start>7</start>
                                <end>21</end>
                            </extent>
                        </part>
                    </relatedItem>
                    <identifier type="eIssn">1470-8744</identifier>
                    <identifier type="MEDLINE">32064678</identifier>
                    <identifier type="ISI">000515325700001</identifier>
                    <identifier type="urn">urn:nbn:de:0070-pub-29412023</identifier>
                    <identifier type="doi">10.1002/bab.1901</identifier>
                    <accessCondition type="use and reproduction" xlink:href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</accessCondition>
                    <recordInfo>
                        <recordIdentifier>bielefeld_pub_2941202</recordIdentifier>
                    </recordInfo>
                    <extension>
                        <vl:doctype>oaArticle</vl:doctype>
                    </extension>
                </mods>
            </mets:xmlData>
        </mets:mdWrap>
    </mets:dmdSec>
    <mets:fileSec>
        <mets:fileGrp USE="pdf upload">
            <mets:file MIMETYPE="application/pdf" ID="FILE0_bielefeld_pub_2941202">
                <mets:FLocat xlink:href="https://pub.uni-bielefeld.de/download/2941202/2942176/wileyDEAL.wendisch.bab.1901.pdf" LOCTYPE="URL"/>
            </mets:file>
        </mets:fileGrp>
    </mets:fileSec>
    <mets:structMap TYPE="LOGICAL">
        <mets:div TYPE="document" ID="bielefeld_pub_2941202" DMDID="DMD2941202">
            <mets:fptr FILEID="FILE0_bielefeld_pub_2941202"/>
        </mets:div>
    </mets:structMap>
</mets:mets>
